Similarly, epicatechin was found to reduce tumor necrosis factor-alpha TNF-α release in an Alzheimer’s disease mouse model, supporting its neuroprotective potential [62]. The gene discussed is TNF; the disease is early-onset autosomal dominant Alzheimer disease.